Search

A team of researchers led by Memorial Sloan Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells -- a subtype of immune cells that suppresses the immune system's reactivity.

… Saturday, January 1, 2011 Summary A team of researchers led by Memorial Sloan Kettering immunologist Alexander Rudensky has gained new understanding about regulatory T cells — a subtype of immune cells that suppresses the immune system’s reactivity. A team of researchers led by Memorial Sloan Kettering

Every year, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences recognizes student research with fellowship awards based on academic excellence.

… Tuesday, September 18, 2018 Summary The Gerstner Sloan Kettering Graduate School of Biomedical Sciences has awarded fellowships to two third-year students and six second-year students through the annual Grayer Fellowships, the Olayan Fellowship, the Robert B. Catell Fellowship, the Palestin Fellowship

Meet Nikki Gioia, who treated for Hodgkin lymphoma at MSK and is now an MSK nurse.

… Wednesday, May 9, 2018 Summary This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to receive

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, August 10, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:  MSK Named Finalist for the 2023 U.S. Legal Department of the Year MSK’s Legal team has been recognized as of one of five finalists for the 2023 U.S. Legal Department of the Year

MSK researchers are learning how cells are able to recognize and correct errors that occur during cell division.

… Tuesday, May 9, 2017 Summary MSK researchers have uncovered new details about how a dividing cell is able to recognize and correct mistakes that occur during mitosis, one of the most important events in cell division. Highlights Studying the mechanisms of cell division gives researchers key insights

Researchers at Memorial Sloan Kettering Cancer Center have found that change in PSA levels over time - known as PSA velocity - is a poor predictor of prostate cancer and may lead to many unnecessary biopsies.

… Thursday, February 24, 2011 Screening for PSA Velocity Leads to Many Unnecessary Biopsies and Should Be Removed from Screening Guidelines Researchers at Memorial Sloan Kettering Cancer Center have found that change in PSA levels over time — known as PSA velocity — is a poor predictor of prostate cancer

Carol Morris, MD, MS, has assumed the position of Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, October 14, 2022 Carol Morris, MD, MS, has assumed the position of Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK). A skilled surgeon and talented leader, Dr. Morris has a deep familiarity with MSK, having previously spent 14 years at the institution as

Mutations that drive cancer growth also make a cell more noticeable to the immune system.

… Wednesday, May 11, 2022 Many cancers contain similar genetic “hotspots” — areas of DNA that are likely to be mutated. For example, more than 50% of cancers contain a mutation in a gene called TP53 , often within a narrow DNA range. Researchers know that hotspots can contribute to cancer development and

Memorial Sloan Kettering Cancer Center (MSK) is ranked the number one hospital in the world for oncology according to Newsweek’s World’s Best Specialized Hospitals 2026 list.

… Thursday, October 30, 2025 Memorial Sloan Kettering Cancer Center (MSK) is ranked the number one hospital in the world for oncology according to  Newsweek’s   World’s Best Specialized Hospitals 2026 list. “Earning the distinction as the world’s top hospital for oncology is a profound honor that reflects

Memorial Sloan Kettering’s Vivian Strong, MD, FACS, addressed peers from around the world in May 2025 at the 16th Annual International Gastric Cancer Congress. Dr. Strong, a surgeon and MSK’s Iris Cantor Chair in Honor of Dr. Sidney Winawer, presented, “Gastric Cancer: A Global Fight for Innovation, the U.S. Perspective,” as the meeting’s Jin Pok Kim Lecturer.

… Thursday, May 8, 2025 Memorial Sloan Kettering’s  Vivian Strong, MD, FACS , addressed peers from around the world in May 2025 at the 16 th Annual International Gastric Cancer Congress. Dr. Strong, a surgeon and MSK’s Iris Cantor Chair in Honor of Dr. Sidney Winawer, presented, “Gastric Cancer: A Global